Phospholipase D2 (PLD2) (Middle Region) Peptid

Details zu Produkt Nr. ABIN981844, Anbieter: Anmelden zum Anzeigen
Proteinname
  • PLD2
  • Pldc
  • phospholipase D2
  • PLD2
  • pld2
  • CpipJ_CPIJ013122
  • VDBG_00892
  • Pld2
Protein Region
Middle Region
Spezies
Human
3
2
2
2
2
1
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-Phospholipase D2 Antikörper (PLD2) (Middle Region) (ABIN2777719)
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PLD2 antibody (Catalog #: ARP33044_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Hintergrund Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-14 AF033850.1 61-74 15-614 BC015033.1 1-600 615-1279 BC056871.1 549-1213 1280-1830 BC015033.1 1266-1816 1831-1995 BC056871.1 1765-1929 1996-3489 BC015033.1 1982-3475

Alias Symbols: -

Protein Interaction Partner: EGFR,PLCG1,ACTB,ACTN1,ALDOA,ALDOC,AMPH,AQP3,ARF1,BIN1,CAV1,CSK,DPYSL2,EGFR,FYN,GAPDH,GM2A,LCK,MTOR,OPRM1,PEA15,PIP5K1A,PLCG1,PRKCA,PRKCD,RPTOR,STXBP1,ALDOA,AMPH,AQP3,ARF1,Actb,BIN1,CAV1,CAV2,EGFR,GAPDH,MTOR,OPRM1,PEA15,PLCG1,PRKCA,PRKCD,RPTOR,SRC

Protein Size: 933
Molekulargewicht 106 kDa
Gen-ID 5338
NCBI Accession NM_002663, NP_002654
UniProt O14939
Applikations-hinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.